BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32545906)

  • 1. Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework.
    Capina R; Li K; Kearney L; Vandamme AM; Harrigan PR; Van Laethem K
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
    Lee ER; Gao F; Sandstrom P; Ji H
    Viruses; 2020 May; 12(5):. PubMed ID: 32429382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
    Ávila-Ríos S; Parkin N; Swanstrom R; Paredes R; Shafer R; Ji H; Kantor R
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32516949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays.
    Becker MG; Liang D; Cooper B; Le Y; Taylor T; Lee ER; Wu S; Sandstrom P; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.
    Ji H; Parkin N; Gao F; Denny T; Jennings C; Sandstrom P; Kantor R
    Viruses; 2020 May; 12(5):. PubMed ID: 32443529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing.
    Jennings C; Parkin NT; Zaccaro DJ; Capina R; Sandstrom P; Ji H; Brambilla DJ; Bremer JW
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
    Ji H; Enns E; Brumme CJ; Parkin N; Howison M; Lee ER; Capina R; Marinier E; Avila-Rios S; Sandstrom P; Van Domselaar G; Harrigan R; Paredes R; Kantor R; Noguera-Julian M
    J Int AIDS Soc; 2018 Oct; 21(10):e25193. PubMed ID: 30350345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
    Lee ER; Parkin N; Jennings C; Brumme CJ; Enns E; Casadellà M; Howison M; Coetzer M; Avila-Rios S; Capina R; Marinier E; Van Domselaar G; Noguera-Julian M; Kirkby D; Knaggs J; Harrigan R; Quiñones-Mateu M; Paredes R; Kantor R; Sandstrom P; Ji H
    Sci Rep; 2020 Jan; 10(1):1634. PubMed ID: 32005884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.
    Manyana S; Gounder L; Pillay M; Manasa J; Naidoo K; Chimukangara B
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34208165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing.
    Noguera-Julian M; Lee ER; Shafer RW; Kantor R; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32575676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of Next-generation Sequencing Techniques in the Dynamics of HIV-1 Quasispecies].
    Zhang J; Xing H
    Bing Du Xue Bao; 2015 Sep; 31(5):573-8. PubMed ID: 26738298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.
    Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H
    Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.
    Jenkins F; Le T; Farhat R; Pinto A; Anzari A; Bonsall D; Golubchik T; Bowden R; Lee FJ; van Hal SJ
    J Med Virol; 2023 Dec; 95(12):e29273. PubMed ID: 38050831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Sequencing for HIV-1 Drug Resistance Testing-A Special Issue Walkthrough.
    Kantor R
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technologies for HIV-1 drug resistance testing: inventory and needs.
    Metzner KJ
    Curr Opin HIV AIDS; 2022 Jul; 17(4):222-228. PubMed ID: 35762377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
    Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
    J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.